1 week Ago By ABMN Staff
UiPath ( NYSE:PATH – Free Report ) had its price target increased by Wells Fargo & Company from $14.00 to $15.00 in a report released on Friday, Benzinga reports.
They currently have an equal weight rating on the healthcare company’s stock. Several other analysts have also recently issued reports on PATH. KeyCorp reaffirmed a sector weight rating on shares of UiPath in a report on Thursday, May 30th.
Needham & Company LLC reaffirmed a hold rating on shares of UiPath in a research report on Friday. DA Davidson lowered their price target on UiPath from $24.00 to $13.
00 and set a neutral rating for the company in a report on Thursday, May 30th. Bank of America raised their price objective on UiPath from $16.00 to $18.
00 and gave the stock a neutral rating in a research note on Friday. Finally, JPMorgan Chase & Co. lowered their target price on shares of UiPath from $28.
00 to $19.00 and set an overweight rating for the company in a research note on Thursday, May 30th. Sixteen equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company.
Based on data from MarketBeat, the stock has an average rating of Hold and an average price target of $17.71. Check Out Our Latest Report on UiPath UiPath Stock Down 6.
0 % UiPath ( NYSE:PATH – Get Free Report ) last posted its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.
03 by $0.01. UiPath had a negative net margin of 6.
41% and a negative return on equity of 2.97%. The company had revenue of $316.
00 million during the quarter, compared to analysts’ expectations of $303.69 million. During the same period in the prior year, the company posted ($0.
09) EPS. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis.
On average, equities analysts anticipate that UiPath will post -0.22 earnings per share for the current year. Institutional Trading of UiPath Several large investors have recently added to or reduced their stakes in the business.
Vanguard Group Inc. grew its stake in shares of UiPath by 5.6% in the first quarter.
Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock worth $911,741,000 after purchasing an additional 2,133,078 shares in the last quarter. State Board of Administration of Florida Retirement System lifted its position in UiPath by 0.
5% in the first quarter. State Board of Administration of Florida Retirement System now owns 295,370 shares of the healthcare company’s stock worth $6,696,000 after purchasing an additional 1,571 shares during the period. Mitsubishi UFJ Trust & Banking Corp boosted its stake in UiPath by 4.
2% during the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 231,694 shares of the healthcare company’s stock valued at $5,240,000 after purchasing an additional 9,393 shares in the last quarter. Acadian Asset Management LLC raised its position in UiPath by 245.
1% in the first quarter. Acadian Asset Management LLC now owns 45,700 shares of the healthcare company’s stock worth $1,032,000 after acquiring an additional 32,456 shares in the last quarter. Finally, Neuberger Berman Group LLC boosted its position in shares of UiPath by 38.
4% during the 4th quarter. Neuberger Berman Group LLC now owns 20,133 shares of the healthcare company’s stock valued at $500,000 after purchasing an additional 5,586 shares in the last quarter. 62.
50% of the stock is currently owned by institutional investors and hedge funds. About UiPath ( Get Free Report ) UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter ..
